Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer

Cancer

Volumn 113, Issue 9, 2008, Pages 2565-2574

  Moran, Meena S ^a   Yang, Qifeng ^b,c   Harris, Lyndsay N ^a   Jones, Beth ^a   Tuck, David P ^a   Haffty, Bruce G ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANDONG UNIVERSITY   (China)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

African American; Breast cancer; Breast conservation therapy; Disparities; p53; Radiation

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; PROGESTERONE; PROTEIN P53; VINCRISTINE;

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; EUROPEAN AMERICAN; FEMALE; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE DIFFERENCE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AFRICAN AMERICANS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; COMBINED MODALITY THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 55549126458     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23881     Document Type: Article

References (64)

1. American Cancer Society. Cancer Facts & Figures for African American 2007-2008. Atlanta, GA: American Cancer Society; 2007.
2. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94:2766-2792.
3. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95:1276-1299.
4. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56:168-183.
5. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-954.
6. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86:705-712.
7. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer. 2000;88:114-123.
8. Freeman HP, Wasfie TJ. Cancer of the breast in poor black women. Cancer. 1989;63:2562-2569.
9. Liberman L, Freeman HP, Chandra S, et al. Carcinoma detection at the breast examination center of Harlem. Cancer. 2002;95:8-14.
10. Gordon NH, Crowe JP, Brumberg DJ, Berger NA. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol. 1992;135:609-618.
11. Coates RJ, Clark WS, Eley JW, Greenberg RS, Huguley CM Jr, Brown RL. Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst. 1990;82:1684-1692.
12. Bassett MT, Krieger N. Social class and black-white differences in breast cancer survival. Am J Public Health. 1986;76:1400-1403.
13. Perkins P, Cooksley CD, Cox JD. Breast cancer. Is ethnicity an independent prognostic factor for survival? Cancer. 1996;78:1241-1247.
14. Simon MS, Severson RK. Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer. 1996;77:308-314.
15. Franzini L, Williams AF, Franklin J, Singletary SE, Theriault RL. Effects of race and socioeconomic status on survival of 1,332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol. 1997;4:111-118.
16. Newman LA, Mason J, Cote D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast. Cancer. 2002;94:2844-2854.
17. Howard DL, Penchansky R, Brown MB. Disaggregating the effects of race on breast cancer survival. Fam Med. 1998;30:228-235.
18. Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer. 1998;82:1310-1318.
19. El-Tamer MB, Homel P, Wait RB. Is race a poor prognostic factor in breast cancer? J Am Coll Surg. 1999;189:41-45.
20. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999;91:1487-1491.
21. Ansell D, Whitman S, Lipton R, Cooper R. Race, income, and survival from breast cancer at 2 public hospitals. Cancer. 1993;72:2974-2978.
22. Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, Van Durme DJ, Krischer JP. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer. 2000;89:2202-2213.
23. Neale AV. Racial and marital status influences on 10 year survival from breast cancer. J Clin Epidemiol. 1994;47:475-483.
24. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94:490-496.
25. Du Xianglin L, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis. 2007;17:122-128.
26. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
27. Norton KS, Johnson LW, Li BD. Compliance and outcomes: do African Americans with advanced breast cancer fare worse? J La State Med Soc. 2005;157:28-30.
28. Joslyn SA. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer. 2002;95:1759-1766.
29. Mehrotra J, Ganpat MM, Kanaan Y, et al. Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res. 2004;10:2052-2057.
30. Guillemette C, Millikan RC, Newman B, Housman DE. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res. 2000;60:950-956.
31. Shiao YH, Chen VW, Scheer WD, Wu XC, Correa P. Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res. 1995;55:1485-1490.
32. Chen Z, Wu AH, Gauderman WJ, et al. Does mammographic density reflect ethnic differences in breast cancer incidence rates? Am J Epidemiol. 2004;159:140-147.
33. Li Y, Millikan RC, Bell DA, et al. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res. 2004;6:R460-R473.
34. Porter PL, Lund MJ, Lin MG, et al. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer. 2004;100:2533-2542.
35. Jones BA, Kasl SV, Howe CL, et al. African-American/white differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer. 2004;101:1293-1301.
36. Millikan RC, Player J, de Cotret AR, et al. Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Res. 2004;6:R264-R274.
37. Poola I, Clarke R, DeWitty R, Leffall LD. Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women. Cancer. 2002;94:615-623.
38. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12:997-1003.
39. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
40. de la Rochefordiere A, Asselain B, Campana F, et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet. 1993;341:1039-1043.
41. Recht A, Connolly JL, Schnitt SJ, et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1988;14:3-10.
42. Fowble BL, Shultz DJ, Overmoyer B, et al. The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys. 1994;30:23-33.
43. Simon MS, Banerjee M, Crossley-May H, Vigneau FD, Noone AM, Schwartz K. Racial differences in breast cancer survival in the Detroit Metropolitan area. Breast Cancer Res. Treat. 2006;97:149-155.
44. Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24:1357-1362.
45. Du Xianglin L, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis. 2007;17:122-128.
46. Haffty BG, Fischer D, Fischer JJ. Regional nodal irradiation in the conservative treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1990;19:859-865.
47. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000;80:1943-1949.
48. Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N. Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer. 2001;91(8 suppl):1679-1687.
49. Natarajan N, Nemoto T, Mettlin C, Murphy GP. Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer. 1985;56:1704-1709.
50. Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97:134-147.
51. Joslyn SA. Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat. 2002;73:45-59.
52. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97:439-448.
53. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer. 2007;109:1721-1728.
54. Carey LA, Livasy CA, Dressler LG, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492-2503.
55. Carey LA, Perou CM, Cressier LG, et al. Race and the poor prognosis basal breast tumor (BTT) phenotype in the population based Carolina Breast Cancer Study (CBCS). J Clin Oncol. 2004;22:9510.
56. Pierce L, Fowble B, Solin LJ, Schultz DJ, Rosser C, Goodman RL. Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome. Cancer. 1992;69:2831-2841.
57. Connor CS, Touijer AK, Krishnan L, Mayo MS. Local recurrence following breast conservation therapy in African-American women with invasive breast cancer. Am J Surg. 2000;179:22-26.
58. Burri SH, Landry JC, Davis LW. Breast conservation is an effective option in Black, medically indigent patients. J Natl Med Assoc. 2002;94:453-458.
59. Burri SH, Landry JC, Norton HJ, Davis LW. Black and white patients fare equally well when treated with postlumpectomy radiotherapy. J Natl Med Assoc. 2004;96:961-967.
60. Newman LA, Kuerer HM, Hunt KK, et al. Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy. Ann Surg Oncol. 1999;6:241-248.
61. Nicolaou N, Fowble B, Hanlon A. The impact of regional lymphatic irradiation and of the extent of axillary lymph node dissection on regional control in patients with early-stage, node-positive breast cancer, treated with breast-conserving therapy. Proc Am Soc Clin Oncol. 1999;18:266.
62. Jones BA, Kasl SV, Howe CL, et al. African-American/white differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer. 2004;101:1293-1301.
63. Porter PL, Lund MJ, Lin MG, et al. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer. 2004;100:2533-2542.
64. Morris GJ, Topham AK, Guiles F, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer. 2007;110:876-884.